Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers-Reference-Cited by-同舟云学术

Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers

Published:2013-12-20 Issue:1 Volume:77 Page:141-148
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Markert Christoph¹,Schweizer Yvonne¹,Hellwig Regina¹,Wirsching Theresia¹,Riedel Klaus-Dieter¹,Burhenne Juergen¹,Weiss Johanna¹,Mikus Gerd¹,Haefeli Walter E.¹

Affiliation:

1. Department of Clinical Pharmacology and Pharmacoepidemiology; University of Heidelberg; Heidelberg Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12177/fullpdf

Reference30 articles.

1. Bosentan therapy for pulmonary arterial hypertension;Rubin;N Engl J Med,2002

2. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension;Galiè;Eur Heart J,2009

3. Warfarin and bosentan interaction in a patient with pulmonary hypertension secondary to bilateral pulmonary emboli;Spangler;Clin Ther,2010

4. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil;Treiber;Drug Metab Dispos,2007

5. Clinical pharmacology of bosentan, a dual endothelin receptor antagonist;Dingemanse;Clin Pharmacokinet,2004

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DRUG TRANSPORT IN THE LIVER;Drug Transporters;2022-04-05

2. Interpretation of Drug Interaction Using Systemic and Local Tissue Exposure Changes;Pharmaceutics;2020-05-02

3. Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients;Journal of Antimicrobial Chemotherapy;2019-05-24

4. Clinical Aspects of Transporter‐Mediated Drug–Drug Interactions;Clinical Pharmacology & Therapeutics;2019-03-18

5. Arzneimitteltherapiesicherheit: Interaktionen – Endothelin- Rezeptorantagonisten;Deutsches Ärzteblatt Online;2018-03-30